Bergenfeldt M, Ohlsson K
Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Gastroenterol Jpn. 1993 Oct;28(5):687-98. doi: 10.1007/BF02806350.
Whole-blood chemiluminescence and levels of leukocyte proteases and plasma protease inhibitors were studied in 43 patients with acute, generalized peritonitis. An almost three-fold increase in whole-blood chemiluminescence was found in acute peritonitis, which may indicate activation or "priming" of the leukocytes by blood-borne factors. High levels of leukocyte elastase and neutrophil proteinase 4(3) were found in plasma and peritoneal exudate. Patients with sepsis had higher plasma levels of both proteases than other patients. Large variations in the plasma levels among patients decreased their sensitivity as markers of infectious complications during the postoperative period. The plasma levels of the protease inhibitors followed three different patterns of reaction. The acute phase proteins alpha 1-proteinase inhibitor and C1-inactivator, increased during the first week of disease, to normalise later in its course. alpha 2-macroglobulin, antithrombin III and alpha 2-antiplasmin were all decreased from onset and normalised later in the course, while secretory leukocyte protease inhibitor showed a slow decrease throughout the course of disease. In peritonitis exudate, the levels of the main protease inhibitors, alpha 1-Proteinase Inhibitor and alpha 2-Macroglobulin, were decreased, probably due to complexation and subsequent elimination, as a part of the defense against liberated leukocyte proteases. The immunoreactive and especially functional levels of the protease inhibitors alpha 2-Antiplasmin, Antithrombin III and C1-Inactivator were also decreased in the exudate, indicating an increased turn-over of these proteins through activation of the cascade systems and/or break-down by leukocyte proteases. In contrast to the other inhibitors, secretory leukocyte protease inhibitor showed higher levels in exudate than in plasma, and unexpectedly high exudate/plasma-quotients were seen in cases with colonic perforations. Degradation of complement factor 3 (C3) and decreased "opsonic capacity" were found in exudate. The "opsonic capacity" could be correlated to the levels of leukocyte proteases in the exudate, which indicates that degradation of complement factor 3 may have been at least partly due to the action of leukocyte proteases. Further depletion of complement factors in exudates of long-standing peritonitis or abscesses may create a vicious circle of deficient opsonisation and clearance of bacteria, as earlier reported for chronic pleural exudates.
对43例急性弥漫性腹膜炎患者的全血化学发光以及白细胞蛋白酶和血浆蛋白酶抑制剂水平进行了研究。发现急性腹膜炎患者的全血化学发光增加了近三倍,这可能表明血源性因子激活或“启动”了白细胞。在血浆和腹腔渗出液中发现白细胞弹性蛋白酶和中性粒细胞蛋白酶4(3)水平较高。脓毒症患者血浆中这两种蛋白酶的水平均高于其他患者。患者之间血浆水平差异较大,降低了它们作为术后感染并发症标志物的敏感性。血浆蛋白酶抑制剂水平呈现三种不同的反应模式。急性期蛋白α1-蛋白酶抑制剂和C1-灭活剂在疾病的第一周升高,随后在病程中恢复正常。α2-巨球蛋白、抗凝血酶III和α2-抗纤溶酶从疾病发作开始就降低,随后在病程中恢复正常,而分泌型白细胞蛋白酶抑制剂在整个疾病过程中呈缓慢下降趋势。在腹膜炎渗出液中,主要蛋白酶抑制剂α1-蛋白酶抑制剂和α2-巨球蛋白的水平降低,这可能是由于形成复合物并随后被清除,作为对抗释放的白细胞蛋白酶的防御机制的一部分。渗出液中蛋白酶抑制剂α2-抗纤溶酶、抗凝血酶III和C1-灭活剂的免疫反应性水平,尤其是功能水平也降低,这表明这些蛋白质通过级联系统的激活和/或白细胞蛋白酶的分解而周转增加。与其他抑制剂不同,分泌型白细胞蛋白酶抑制剂在渗出液中的水平高于血浆,在结肠穿孔病例中观察到渗出液/血浆比值意外地高。在渗出液中发现补体因子3(C3)降解且“调理能力”降低。“调理能力”与渗出液中白细胞蛋白酶的水平相关,这表明补体因子3的降解可能至少部分是由于白细胞蛋白酶的作用。长期腹膜炎或脓肿渗出液中补体因子的进一步消耗可能会形成调理作用不足和细菌清除障碍的恶性循环,正如之前关于慢性胸腔渗出液的报道。